Pomerantz LLP Appointed Lead Counsel in EDAP TMS S.A.
On October 24, 2014, Pomerantz LLP was appointed Lead Counsel in In re EDAP TMS S.A. SECURITIES LITIGATION.
Pomerantz LLP featured in The London Evening Standard
Pomerantz LLP has been featured in the London Evening Standard, one of the largest news publications in the UK, regarding our cutting-edge lawsuit against BP.
Pomerantz LLP Appointed Interim Lead Counsel in LIBOR Antitrust Litigation
On October 14, 2014, Pomerantz LLP was appointed Interim Lead Counsel on behalf of a Class of Lenders and financial institutions.
Pomerantz LLP Appointed Lead Counsel in Galena Biopharma, Inc.
On October 3, 2014, Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against Galena Biopharma, Inc.
Pomerantz LLP Appointed Lead Counsel in Barclays PLC
On October 2, 2014 Pomerantz LLP was appointed lead counsel in Barclays PLC.
Pomerantz LLP Appointed Lead Counsel in Regado Biosciences, Inc.
On September 26, 2014, Pomerantz LLP was appointed Lead Counsel in Regado Biosciences, Inc.
Pomerantz Appointed Lead Counsel in OvaScience, Inc.
On September 25, 2014, Pomerantz was appointed Lead Counsel in a class action lawsuit against OvaScience, Inc and certain of its officers.
Additional Successes in Pomerantz’s Landmark BP Litigation
In October 2014, Pomerantz once again secured crucial victories in its ground-breaking litigation over British Petroleum’s 2010 Gulf of Mexico oil spill. This time, Pomerantz established the right of individual foreign investors who purchased foreign-traded shares of a foreign corporation to pursue claims for securities fraud in a U.S. court, thereby overcoming obstacles created by the U.S. Supreme Court’s decision in Morrison v. Nat’l Australia Bank Ltd.
A year prior, Pomerantz defeated BP’s motion to dismiss similar claims by individual U.S. public pension funds. Read More